Juvelook Volume 200 mg — broad, gradual support under the skin
Unlike the dermal Juvelook products, Volume is injected under the skin. What it does when broad areas of the face have hollowed. No prices or photos.
The short answer
Juvelook Volume is a 200 mg vial (170 mg PDLLA + 30 mg HA) with a mean 40 µm particle, positioned by the manufacturer for subcutaneous volume. The hyaluronic acid fills first; collagen then forms around the PDLLA to support the base. In aged mice, PDLLA increased subcutaneous fat thickness. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu; +82 53-428-2700) stocks it for broad, gently hollowed areas such as the cheeks.
Specifications
| Item | Detail |
|---|---|
| Vial | 200 mg (170 mg PDLLA + 30 mg HA) |
| Mean particle | 40 µm |
| Layer / use | Subcutaneous, volume |
| Smaller dose, same particle | Volume 100 (100 mg) |
| Approval | Tissue-repair material, class IV device; approved for temporary improvement of facial wrinkles in adults |
What happens under the skin
- Straight away — hyaluronic acid adds volume.
- Weeks to months — collagen forms around the PDLLA and firms the base.
- Fat layer — in aged mice, PDLLA raised adipogenic factors (PPAR-γ, C/EBP-α) and subcutaneous fat thickness without enlarging fat cells.
Where we use it
Where a deep hollow needs shape straight away, I shape it first with dissolvable hyaluronic acid filler and then build the base with Juvelook. I start small and decide whether to add after seeing the face again a few weeks later.
Compared with Volume 100 and G
| Product | Vial | Mean particle | Best for |
|---|---|---|---|
| Volume 100 | 100 mg | 40 µm | One or two areas |
| Volume | 200 mg | 40 µm | Broad areas |
| G | 200 mg | 65 µm | Broad, deep areas, contouring |
Juvelook Volume 200 mg FAQ
Volume vs Juvelook?
Juvelook (50 mg, 24 µm) is dermal; Volume (200 mg, 40 µm) is subcutaneous and aimed at volume.
Where is Volume used?
Broad, gently hollow areas such as the cheeks and temples.
Volume vs filler?
Filler shapes immediately; Volume builds support gradually as collagen forms. Deep areas can be shaped with filler first and supported with Volume.
Where can I get a Juvelook consultation in Daegu?
Miso Clinic is on the 4th floor of the Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82 53-428-2700. Weekdays 11:00–19:00, Saturdays 10:00–16:00, closed Sundays and public holidays. The clinic stocks the full Juvelook line (i, Skin, Juvelook, Volume 100, Volume and G).
Read next
Product pages
Product page: Juvelook — PDLLA with hyaluronic acid
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, director of Miso Clinic, Daegu. The treatment standards and injection design set out here are the ones we use in practice.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- Manufacturer product page — juvelook.co.kr (VAIM Co., Ltd.). Juvelook I and Skin 30 mg, Juvelook 50 mg, Volume 100 100 mg, Volume and G 200 mg, all 85% PDLLA and 15% hyaluronic acid. Registered in Korea as a class IV medical device (tissue-repair material) for the temporary improvement of facial wrinkles in adults.
- Manufacturer brochures — VAIM Juvelook, Juvelook i and Juvelook G brochures (obtained by Miso Clinic, October 2026). Mean particle size i 20, Juvelook 24, Volume 40, G 65 µm; layer per product (i and Juvelook dermis, Volume and G subcutaneous); store below 30 °C, do not freeze; porous mesh-structured particles.
- Subcutaneous fat — Byun KA et al., Int J Mol Sci 2024;25(23):12739, PMID 39684448. In aged mice PDLLA raised adipogenic factors and subcutaneous fat thickness without enlarging fat cells.
- Collagen and stem-cell mechanism — Oh S et al., Antioxidants 2023;12(6):1204, PMID 37371934. M2 polarisation of senescent macrophages, adipose-derived stem cell proliferation and more type I and III collagen (cells and aged mice).
- How Miso Clinic works — full Juvelook line in stock (confirmed by the director, 14–15 October 2026); concern, then layer, then product; start small and review after a few weeks; deep hollows shaped first with dissolvable hyaluronic acid filler; sagging addressed first with lifting; other options first under the eyes. Source of every “I” or “we” sentence in this column.
- Korean medical advertising law — Medical Service Act art. 56(2) and 27(3). No testimonials, before-and-after photos or prices appear here. Results and how long they last vary from person to person.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English